Supplementation of Omega-3 PUFAs could improve long term prognosis after pci in patients without hyperlipidemia and diabetes

      Aim: Cardiovascular events could occur in patients without hyperlipidemia and diabetes, and some of them repeat events. Several study reported that reduced Omega-3 PUFAs are risks for those patients. Thus we conducted this study to investigate whether supplementation of Omega-3 PUFAs improve long term prognosis of patients without dyslipidemia and diabetes or not.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect